MDMA-assisted Prolonged Exposure Therapy for Comorbid Alcohol Use Disorder and Post-traumatic Stress Disorder
Condition: PTSD · Alcohol Use Disorder · Alcohol Dependence · Sponsor: University of Sydney
About this study
To explore the effectiveness of of MDMA-assisted prolonged exposure therapy in improving treatment outcomes for individuals with comorbid PTSD and alcohol use disorder in a double-blind randomised placebo-controlled trial.
This description comes directly from the study's public registry record.
Talk to the study team
Kirsten C Morley, PhD · 61295153636 · Kirsten.morley@sydney.edu.au
Ellen Towers · ellen.towers@sydney.edu.au
Always discuss trial participation with your own doctor first.
Locations (2)
| Drug Health Services, Royal Prince Alfred Hospital | Sydney, New South Wales, Australia | Recruiting |
| Turning Point | Richmond, Victoria, Australia | Not Yet Recruiting |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05709353